Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

Clinical trial NCT06696417 · RECRUITING

Trial details

NCT number: NCT06696417
Sponsor: First Hospital of China Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2025-02-17
Primary completion: 2028-04-01
Enrollment: 1516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.